MTACW (MedTech Acquisition) Operating Margin %: 0.00% (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTACW MedTech Acquisition Corp MTACW
22 GF Score
Price $0.22
! 2 Warning Signs
View Full Analysis

What is MedTech Acquisition Operating Margin %?

MedTech Acquisition MTACW +21.11% 22 Operating Margin % is 0.00% as of Jun. 2023. GuruFocus rates MTACW with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Operating Margin % is calculated as Operating Income divided by its Revenue. MedTech Acquisition's Operating Income for the three months ended in Jun. 2023 was $-1.43 Mil. MedTech Acquisition's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, MedTech Acquisition's Operating Margin % for the quarter that ended in Jun. 2023 was 0.00%.

The historical rank and industry rank for MedTech Acquisition's Operating Margin % or its related term are showing as below:


MTACW's Operating Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 8.71
* Ranked among companies with meaningful Operating Margin % only.

MedTech Acquisition's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

MedTech Acquisition's Operating Income for the three months ended in Jun. 2023 was $-1.43 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2023 was $-4.06 Mil.


MedTech Acquisition  (NAS:MTACW) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


MedTech Acquisition Operating Margin % Related Terms


MedTech Acquisition Operating Margin % Historical Data

* Premium members only.

The historical data trend for MedTech Acquisition's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedTech Acquisition Operating Margin % Chart

MedTech Acquisition Annual Data
Trend Dec20 Dec21 Dec22
Operating Margin %
0.00 0.00 0.00

MedTech Acquisition Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MTACW vs MON, HCII, SCAQ: Operating Margin % Comparison

For the Shell Companies subindustry, MedTech Acquisition's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedTech Acquisition Operating Margin % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, MedTech Acquisition's Operating Margin % distribution charts can be found below:

* The bar in red indicates where MedTech Acquisition's Operating Margin % falls into.


MTACW
22GF Score
MedTech Acquisition Corp MTACW
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedTech Acquisition Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

MedTech Acquisition's Operating Margin % for the fiscal year that ended in Dec. 2022 is calculated as

Operating Margin %=Operating Income (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=-2.746 / 0
= %

MedTech Acquisition's Operating Margin % for the quarter that ended in Jun. 2023 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=-1.43 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
MedTech Acquisition (MTACW) has a Operating Margin % of 0.00% as of Jun. 2023. Operating margin is the ratio of total operating income to net sales. View historical data on MedTech Acquisition and its competitors.
Is MedTech Acquisition's Operating Margin % too high?
MedTech Acquisition's current Operating Margin % is 0.00%. Overall, MedTech Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does MedTech Acquisition's Operating Margin % compare to MON and HCII?
MedTech Acquisition's Operating Margin % of 0.00% can be compared against companies in the Diversified Financial Services industry. The industry median Operating Margin % is 8.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Diversified Financial Services company?
The median Operating Margin % among Diversified Financial Services companies is 8.71, based on 77 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on MedTech Acquisition and its competitors. For the Diversified Financial Services industry, the median Operating Margin % is 8.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedTech Acquisition's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Acquisition stock overvalued right now?
MedTech Acquisition (MTACW) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. MedTech Acquisition's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For MedTech Acquisition (MTACW), the current Operating Margin % is 0.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedTech Acquisition Business Description

Address 48 Maple Avenue, Greenwich, CT, USA, 06830
MedTech Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for MTACW

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price